KALA BIO, Inc.(KALA)

Biotechnology · Arlington, MA

$0.38+0.01 (+3.78%)

Delayed quote: Oct 6, 2026, 11:09 AM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T15:12:47.195Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:12:47.195Z.

Quote observation: 2026-10-06T15:09:57.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -81.82
Quote price: 0.3762

FMP input reference: 2fde06f259e28fcaf0a0d51df993d991938700e907f86078bced96cac1655d96

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

KALA Earnings Yield Metrics

EARNINGS YIELD

N/A

KALA Competitors' Earnings Yield

KALA

KALA BIO, Inc.

Current

Market Cap

$7.28M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INM

InMed Pharmaceuticals Inc.

vs KALA

Market Cap

$7.31M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LGVN

Longeveron Inc.

vs KALA

Market Cap

$7.47M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NRSN

NeuroSense Therapeutics Ltd.

vs KALA

Market Cap

$7.22M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CURX

Curanex Pharmaceuticals Inc Common Stock

vs KALA

Market Cap

$7.13M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CODX

Co-Diagnostics, Inc.

vs KALA

Market Cap

$7.07M

Earnings Yield

N/A

TTM Avg

21.79%

3Y Avg

16.65%

5Y Avg

16.65%

MGRX

Mangoceuticals, Inc.

vs KALA

Market Cap

$7.08M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACON

Aclarion, Inc.

vs KALA

Market Cap

$6.73M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENVB

Enveric Biosciences, Inc.

vs KALA

Market Cap

$6.67M

Earnings Yield

N/A

TTM Avg

2.14%

3Y Avg

1.65%

5Y Avg

1.48%

GTBP

GT Biopharma, Inc.

vs KALA

Market Cap

$7.93M

Earnings Yield

N/A

TTM Avg

1206.46%

3Y Avg

1192.40%

5Y Avg

1192.40%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
KALA BIO, Inc. (KALA)	$7.28M	N/A	N/A	N/A	N/A
InMed Pharmaceuticals Inc. (INM)vs ›	$7.31M	N/A	N/A	N/A	N/A
Longeveron Inc. (LGVN)vs ›	$7.47M	N/A	N/A	N/A	N/A
NeuroSense Therapeutics Ltd. (NRSN)vs ›	$7.22M	N/A	N/A	N/A	N/A
Curanex Pharmaceuticals Inc Common Stock (CURX)vs ›	$7.13M	N/A	N/A	N/A	N/A
Co-Diagnostics, Inc. (CODX)vs ›	$7.07M	N/A	21.79%	16.65%	16.65%
Mangoceuticals, Inc. (MGRX)vs ›	$7.08M	N/A	N/A	N/A	N/A
Aclarion, Inc. (ACON)vs ›	$6.73M	N/A	N/A	N/A	N/A
Enveric Biosciences, Inc. (ENVB)vs ›	$6.67M	N/A	2.14%	1.65%	1.48%
GT Biopharma, Inc. (GTBP)vs ›	$7.93M	N/A	1206.46%	1192.40%	1192.40%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

KALA Earnings Yield Metrics

KALA Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics